Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;26(1):19-21.
doi: 10.1080/08998280.2013.11928902.

T-cell prolymphocytic leukemia

Robbie L Graham  1 , Barry Cooper, John R Krause
Affiliations

T-cell prolymphocytic leukemia

Robbie L Graham et al. Proc (Bayl Univ Med Cent). 2013 Jan.

Abstract

T-cell prolymphocytic leukemia is a rare and unusual malignancy characterized by the proliferation of small- to medium-sized prolymphocytes of postthymic origin with distinctive clinical, morphologic, immunophenotypic, and cytogenetic features. Involvement of the peripheral blood, bone marrow, lymph nodes, liver, spleen, and skin can occur. The clinical course is typically very aggressive with poor response to conventional chemotherapy and short survival rates, and the only potential long-term curative treatment is hematopoietic stem cell transplantation. We report the case of a man with de novo T-cell prolymphocytic leukemia and discuss the distinctive clinical, morphologic, immunophenotypic, and cytogenetic features of this entity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Morphology of T-cell prolymphocytic leukemia. (a) Peripheral blood stained with Wright's stain (original magnification under oil 1000×). (b) Bone marrow stained with hematoxylin and eosin (original magnification 400×).
See this image and copyright information in PMC

References

    1. Robak T, Robak P. Current treatment options in prolymphocytic leukemia. Med Sci Monit. 2007;13(4):RA69–RA80. - PubMed
    1. Madaris L. T-cell prolymphocytic leukemia: a rare disease in an elderly female. J Am Acad Nurse Pract. 2010;22(12):648–653. - PubMed
    1. Dearden CE, Matutes E, Cazin B, Tjønnfjord GE, Parreira A, Nomdedeu B, Leoni P, Clark FJ, Radia D, Rassam SM, Roques T, Ketterer N, Brito-Babapulle V, Dyer MJ, Catovsky D. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001;98(6):1721–1726. - PubMed
    1. Del Giudice I, Davis Z, Matutes E, Osuji N, Parry-Jones N, Morilla A, Brito-Babapulle V, Oscier D, Catovsky D. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL) Leukemia. 2006;20(7):1231–1237. - PubMed
    1. Ruchlemer R, Parry-Jones N, Brito-Babapulle V, Attolico I, Wotherspoon AC, Matutes E, Catovsky D. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol. 2004;125(3):330–336. - PubMed